Back to announcement
20240402_MERK_Laporan Informasi dan Fakta Material_31622730.pdf
Financial statement Text extracted MERKSource file signed link, expires in 15 minutes
Extracted text 4
Page 1
Go To English Page
Nomor Surat 11acorr/CS/MS/III/2024
Nama Perusahaan Merck Tbk
Kode Emiten MERK
Lampiran 3
Penyampaian Laporan Keuangan (KOREKSI)
Perihal
Mengoreksi surat kami nomor : 11a/CS/MS/III/2024 tanggal 01 April 2024 perihal Penyampaian Laporan Keuangan,
dengan ini perseroan menyampaikan hal sebagai berikut:
Tahun Fiskal : 2023
Tahun Buku : DEC
Jenis Periode : Tahunan / Annual
Dengan ini kami untuk dan atas nama perusahaan menyampaikan laporan keuangan, sebagai berikut:
Nama Emiten : Merck Tbk
Bidang Usaha : Industri Farmasi
Nilai Ekuitas : 795.878.793.000
Nilai Pendapatan Periode Sebelumnya : 1.124.599.738.000
Nilai Pendapatan : 961.433.965.000
Selisih dengan Nilai Pendapatan (163.165.773.000)
:
Periode Sebelumnya
Kurs : Rupiah / IDR
Rate : 1
Jenis Laporan atas Laporan Keuangan : Diaudit / Audited
Opini Audit : Wajar Tanpa Pengecualian / Unqualified
Demikian untuk diketahui.
Hormat Kami,
Merck Tbk
Melisa Sandrianti
Corporate Secretary
Merck Tbk
Jl. TB. Simatupang No. 8, Pasar Rebo, Jakarta Timur
Telepon : 28565600, Fax : 28565601, www.merck.co.id
Page 2
Nama Pengirim Melisa Sandrianti
Jabatan Corporate Secretary
Tanggal dan Waktu 02-04-2024 14:34
Lampiran 1. 11_Penyampaian LK 31 Dec 2023_MERK_28032024.pdf
2. Laporan Keuangan_31.12.2023_MERK_28032024.pdf
3. 13_Penjelasan Perubahan Liabilitas_MERK_28032024.pdf
Dokumen ini merupakan dokumen resmi Merck Tbk yang tidak memerlukan tanda tangan karena dihasilkan secara
elektronik oleh sistem pelaporan elektronik. Merck Tbk bertanggung jawab penuh atas informasi yang tertera
didalam dokumen ini.
Page 3
Go To Indonesian Page
Letter / Announcement No. 11acorr/CS/MS/III/2024
Issuer Name Merck Tbk
Issuer Code MERK
Attachment 3
Subject Submission of Financial Report (CORRECTION)
Correction to our previous announcement number : 11a/CS/MS/III/2024 dated 01 April 2024 with the subject of Material
Information or Facts Report , the company hereby submit the following information:
Fiscal Year : 2023
End of Year : DEC
Period Type : Tahunan / Annual
The company hereby announce the Submission of Financial Report as follows:
Issuer Name : Merck Tbk
Business Fields : Industri Farmasi
Equity Value : 795.878.793.000
Previous Period Revenue : 1.124.599.738.000
Revenue : 961.433.965.000
Difference with Previous Period (163.165.773.000)
:
Revenue
Currency : Rupiah / IDR
Rate : 1
Types of Reports on Financial : Diaudit / Audited
Type of Auditor's Opinion : Wajar Tanpa Pengecualian / Unqualified
Thus to be informed accordingly.
Respectfully,
Merck Tbk
Melisa Sandrianti
Corporate Secretary
Merck Tbk
Jl. TB. Simatupang No. 8, Pasar Rebo, Jakarta Timur
Phone : 28565600, Fax : 28565601, www.merck.co.id
Page 4
Sender Name Melisa Sandrianti
Function Corporate Secretary
Date and Time 02-04-2024 14:34
Attachment 1. 11_Penyampaian LK 31 Dec 2023_MERK_28032024.pdf
2. Laporan Keuangan_31.12.2023_MERK_28032024.pdf
3. 13_Penjelasan Perubahan Liabilitas_MERK_28032024.pdf
This is an official document of Merck Tbk that does not require a signature as it was generated electronically by the
electronic reporting system. Merck Tbk is fully responsible for the information contained within this document.
Names mentioned 2 people and organisations named in the text · linked when the evidence is strong
unresolved
person
Melisa Sandrianti
· Corporate Secretary
p.1 ×2
Extraction attempts how the parser did, and what it refused
Nothing structured was extracted from this document — the attempts below say why.
No extraction attempted yet.